1. Clinical Overview
Sulfasalazine is a disease-modifying anti-rheumatic drug (DMARD) and an anti-inflammatory agent. It is a prodrug, a conjugate of 5-aminosalicylic acid (5-ASA/mesalamine) and sulfapyridine, linked by an azo bond. It is primarily used in the management of inflammatory bowel diseases (ulcerative colitis, Crohn's disease) and rheumatoid arthritis. In the gut, colonic bacteria cleave the azo bond, releasing the active components. Its anti-inflammatory and immunomodulatory effects are central to its therapeutic action.
| Onset | Duration | Bioavailability |
|---|---|---|
| For rheumatoid arthritis: 4-12 weeks for symptomatic improvement. For ulcerative colitis: 1-3 weeks for symptomatic response, with full therapeutic effect for maintenance of remission taking several months. | Approximately 24 hours, necessitating divided daily dosing. | Less than 15% for the intact molecule. Nearly all (90-99%) reaches the colon unchanged where bacterial action releases components. Sulfapyridine bioavailability is about 60-80%. |
2. Mechanism of Action
The exact mechanism is multifactorial and disease-specific. In IBD: The active moiety 5-ASA acts locally in the colonic mucosa as an anti-inflammatory, inhibiting cyclooxygenase and lipoxygenase pathways, scavenging reactive oxygen species, and inhibiting cytokine production. In RA: The sulfapyridine moiety is believed to be responsible for systemic immunomodulatory effects, including inhibition of neutrophil chemotaxis, inhibition of inflammatory pathways (NF-κB), and suppression of B-cell activity and antibody production.
3. Indications & Uses
- Ulcerative Colitis (mild to moderate, maintenance of remission)
- Active Rheumatoid Arthritis (as a DMARD, often in combination therapy)
- Crohn's Disease (particularly colonic)
4. Dosage & Administration
Adult Dosage: RA & IBD: Start with 500 mg daily, increase gradually over 4-6 weeks to target dose. Maintenance: 2-3 g daily in 2-3 divided doses (e.g., 1000mg twice daily). Max daily dose for IBD: 4-6 g. Max daily dose for RA: 3 g.
Administration: Take after food with a full glass of water to reduce GI upset. Swallow tablet whole, do not crush or chew. Maintain adequate hydration. For IBD, enteric-coated tablets are preferred to ensure delivery to colon. Doses should be evenly spaced.
5. Side Effects
Common side effects may include:
- Nausea, vomiting, dyspepsia
- Headache, dizziness
- Anorexia
- Orange-yellow discoloration of urine, sweat, tears, skin
- Reversible oligospermia (male infertility)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Digoxin | Sulfasalazine may reduce bioavailability of digoxin. | Moderate |
| Folic Acid / Folate Antagonists (e.g., Methotrexate, Trimethoprim) | Sulfasalazine inhibits folate absorption and metabolism; may increase risk of megaloblastic anemia. Concurrent use with methotrexate may increase hepatotoxicity and myelosuppression. | Major |
| Warfarin | Sulfasalazine may potentiate anticoagulant effect by displacing warfarin from protein binding sites and reducing vitamin K production by gut flora. | Major |
| Oral Hypoglycemics (Sulfonylureas) | Increased risk of hypoglycemia due to displacement from protein binding. | Moderate |
| Cyclosporine | Sulfasalazine may reduce cyclosporine levels, risking transplant rejection. | Major |
| Antibiotics (broad-spectrum) | May reduce colonic bacterial cleavage of sulfasalazine, decreasing efficacy in IBD. | Moderate |
7. Patient Counselling
- DO take exactly as prescribed, with food and a full glass of water.
- DO keep all scheduled lab appointments for blood and urine tests.
- DO use sun protection (sunscreen, hat) due to photosensitivity risk.
- DO inform all doctors and dentists you are taking this medicine.
- DO take folic acid supplement if advised by your doctor.
- DON'T stop taking suddenly without consulting your doctor.
- DON'T crush, chew, or break the tablet unless instructed (some brands are enteric-coated).
- DON'T take antacids or antibiotics without consulting your doctor.
8. Toxicology & Storage
Overdose: Nausea, vomiting, gastric distress, abdominal pain, drowsiness, convulsions. Severe overdose may lead to hemolytic anemia, agranulocytosis, hepatorenal failure, and crystalluria.
Storage: Store below 30°C in a cool, dry place, protected from light and moisture. Keep the container tightly closed. Keep out of reach of children.